Clinical trial
A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters on Squamous Cell Carcinoma
NCT03353077 is registered in ClinicalTrials.gov with Alpha Tau Medical LTD. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters on Squamous Cell Carcinoma
- Lead sponsor
- Alpha Tau Medical LTD.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 21, 2017
- Completion date
- July 14, 2019
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin squamous cell carcinoma